Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials

NACompletedINTERVENTIONAL
Enrollment

20,707

Participants

Timeline

Start Date

January 30, 2023

Primary Completion Date

July 15, 2024

Study Completion Date

July 15, 2024

Conditions
Cancer
Interventions
OTHER

AI-assisted MatchMiner Platform

A medical record data analysis tool that uses conjunction machine learning and natural language processing models to predict changes in treatment and prognosis and ascertain progression of disease and metastatic sites using retrospective imaging reports. MatchMiner is an established clinical operations tool at Dana-Farber Cancer Institute that links OncoPanel next-generation sequencing data to basic clinical information and clinical trial eligibility criteria to suggest biomarker-selected therapeutic trials for participants.

Trial Locations (1)

02215

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER